Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for nocturia and orthostatic hypotension in Parkinson's disease
ACTRN12609000080224Phase 2Terminated
- Sponsor
- John O'Sullivan
- Start
- Apr 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of desmopressin in nocturia and orthostatic hypotension (OH), sponsored by John O'Sullivan. Primary endpoints: Improvement in COMPASS-OD survey and Number of nocturnal bladder voids. Started Apr 2009; status: terminated.
02
Drugs
desmopressin
03
Conditions
nocturiaorthostatic hypotension (OH)
Beyond the preview
Go deeper on ACTRN12609000080224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000080224.